Spending Often Persists in High-Cost Medicare-Medicaid Eligible

Share this content:
Spending Often Persists in High-Cost Medicare-Medicaid Eligible
Spending Often Persists in High-Cost Medicare-Medicaid Eligible

THURSDAY, Oct. 11, 2018 (HealthDay News) -- More than half of patients who are dually eligible for Medicare and Medicaid and are designated as high-cost in one year remain persistently high-cost over three years, according to a study published online Oct. 2 in the Annals of Internal Medicine.

Jose F. Figueroa, M.D., M.P.H., from Harvard University in Boston, and colleagues used data from the Medicare-Medicaid Linked Enrollee Analytic Data Source (2008 to 2010) to identify 1,928,340 dual-eligible Medicare and Medicaid beneficiaries who were alive all three years. High-cost beneficiaries were defined as having spending in any given year in the top 10 percent for that year.

The researchers found 192,835 high-cost patients in the first year, more than half (54.8 percent) of whom remained high-cost across all three years. Persistently high-cost patients were younger, had fewer medical comorbidities, and had greater intellectual impairment than transiently high-cost patients. Costs per year were $161,224 for persistently high-cost patients compared with $86,333 for transiently high-cost patients and $22,352 for non-high-cost patients. Persistently high-cost patients' spending was mostly related to long-term care (68.8 percent), with very little (<1 percent) related to potentially preventable hospitalizations for ambulatory care-sensitive conditions.

"Strategies to control costs in dual-eligible beneficiaries may be more effective if they focus on reducing spending in long-term care rather than on reducing potentially preventable hospitalizations," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »